{"id":394714,"date":"2020-12-07T16:08:17","date_gmt":"2020-12-07T21:08:17","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=394714"},"modified":"2020-12-07T16:08:17","modified_gmt":"2020-12-07T21:08:17","slug":"annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/","title":{"rendered":"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BERWYN, Pa., Dec.  07, 2020  (GLOBE NEWSWIRE) &#8212; Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria Maccecchini, Ph.D., will present at Benzinga&#8217;s inaugural Global SmallCap Conference on Tuesday, December 8, 2020 at 4:30 pm ET.<\/p>\n<p align=\"justify\">Investors interested in viewing Annovis Bio&#8217;s presentation may register with free access\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C214KlKCxaa5K9WS2zJSliRE_UmQzoEKhQOjyMPFfY7-djoEysciDZXIAZP-vYBsEDZr-BnKldGCtpIU9_xWHZNMWlpMy2YGZcC9mz5OBHc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a>\u00a0for the two-day conference which takes place virtually from December 8-9, 2020.<\/p>\n<p align=\"justify\">During the presentation, Dr. Maccecchini will discuss the Company\u2019s unique approach to AD and other neurodegenerative diseases, current pipeline, and upcoming milestones, including expected publication of data from its current Phase 2a studies in AD and PD.<\/p>\n<p align=\"justify\">\n        <strong>About <\/strong><br \/>\n        <strong>Benzinga<\/strong>\n      <\/p>\n<p align=\"justify\">Benzinga is a leading financial media company dedicated to making information easier to consume. Benzinga&#8217;s news desk is constantly breaking stories and moving billions of dollars of market capitalization through its real-time news tool, Benzinga Pro. Benzinga&#8217;s original content is syndicated to 70 partner websites including Yahoo! Finance MSN, CNNMoney, Fox Business and MarketWatch.<\/p>\n<p align=\"justify\">\n        <strong>About <\/strong><br \/>\n        <strong>Annovis<\/strong><br \/>\n        <strong> Bio<\/strong>\n      <\/p>\n<p align=\"justify\">Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD) and Alzheimer\u2019s in Down Syndrome (AD-DS). We believe that we are the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and, thereby, improves the information highway of the nerve cell, known as axonal transport. When this information flow is impaired, the nerve cell gets sick and dies. We expect our treatment to improve memory loss and dementia associated with AD and AD-DS, as well as body and brain function in PD. We have an ongoing Phase 2a study in AD patients and have commenced a second Phase 2a study in AD and PD patients. For more information on Annovis, please visit the company\u2019s website:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A92zlQGtskx-2BYYhk3JKErymGhqmnbhEFEu2vm9NQG4SlEa1rE3usL9-Kg3KltbUYfSuBtGGFXN6SPnUguwdzAEH0NScs5OSRz45LjPNhLGnvx9mHgwVNAlJGofMAQka_8X_Wk93tZeyg9FezgZuI5Mf0901sUT8C6HXtAFhWWA812Z7y3i0awrS5TSWj7mbEb4tJmHROIaf14oXauRlSWc1CZ47dYPjlNUg9GL-pZ6VbJ_xbdQXtOE7M0Ax6PmmxMJoAvjpWjJZwwh0vrKPe61UOoV3IGNI6sC4CnzobQLmR82onkqpADgftHnNxnj5F2feRyJHZGKzDFwqNqWQI9CSPPlwUQ1ltiJgqIGZTpSIKY184FuSmcDOXP4GK8sNB6e4bCbDDoZr4Zoi-fTTYlkkzsEmqc2LJLvPJJYUA83okT3-2_33jvjLpXdH-X2eBAFn9jVsJTNLFMbt4Xknw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.annovisbio.com<\/a>.<\/p>\n<p>Investor Relations:<\/p>\n<p>Dave Gentry, CEO<br \/>RedChip Companies Inc.<br \/>407-491-4498<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wPkHDHed1fTIg7VZqeMpkGwoby7CwbYpfDhJhhRF21uWkVz3Yhj99pykj2GKelQF915x0vPhaGDOpYiG8436VWahP7T3owU-y5y8GF_nfZ3rx5FppPkI9HknzfPGb3sROS-0s7IUzmqFcLtCXJX3LZRsgC_2JUdbWbOYHzgxPO_qk99yMpbIxkQzZ0zRoOJkUPydgWCllCcbVB7c4TMSZ8OzbdkNcyVMd-9gBHN9PIU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Dave@redchip.com<\/a><\/p>\n<p>SOURCE: Annovis Bio, Inc.<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/2a49330b-f4f6-4284-bb9b-6e6f5b2291fc\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BERWYN, Pa., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria Maccecchini, Ph.D., will present at Benzinga&#8217;s inaugural Global SmallCap Conference on Tuesday, December 8, 2020 at 4:30 pm ET. Investors interested in viewing Annovis Bio&#8217;s presentation may register with free access\u00a0here\u00a0for the two-day conference which takes place virtually from December 8-9, 2020. During the presentation, Dr. Maccecchini will discuss the Company\u2019s unique approach to AD and other neurodegenerative diseases, current pipeline, and upcoming milestones, including expected publication of data from its current Phase 2a studies in AD and PD. About Benzinga Benzinga is a leading &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-394714","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BERWYN, Pa., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria Maccecchini, Ph.D., will present at Benzinga&#8217;s inaugural Global SmallCap Conference on Tuesday, December 8, 2020 at 4:30 pm ET. Investors interested in viewing Annovis Bio&#8217;s presentation may register with free access\u00a0here\u00a0for the two-day conference which takes place virtually from December 8-9, 2020. During the presentation, Dr. Maccecchini will discuss the Company\u2019s unique approach to AD and other neurodegenerative diseases, current pipeline, and upcoming milestones, including expected publication of data from its current Phase 2a studies in AD and PD. About Benzinga Benzinga is a leading &hellip; Continue reading &quot;Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-07T21:08:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020\",\"datePublished\":\"2020-12-07T21:08:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/\"},\"wordCount\":344,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/\",\"name\":\"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=\",\"datePublished\":\"2020-12-07T21:08:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/","og_locale":"en_US","og_type":"article","og_title":"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020 - Market Newsdesk","og_description":"BERWYN, Pa., Dec. 07, 2020 (GLOBE NEWSWIRE) &#8212; Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria Maccecchini, Ph.D., will present at Benzinga&#8217;s inaugural Global SmallCap Conference on Tuesday, December 8, 2020 at 4:30 pm ET. Investors interested in viewing Annovis Bio&#8217;s presentation may register with free access\u00a0here\u00a0for the two-day conference which takes place virtually from December 8-9, 2020. During the presentation, Dr. Maccecchini will discuss the Company\u2019s unique approach to AD and other neurodegenerative diseases, current pipeline, and upcoming milestones, including expected publication of data from its current Phase 2a studies in AD and PD. About Benzinga Benzinga is a leading &hellip; Continue reading \"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-07T21:08:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020","datePublished":"2020-12-07T21:08:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/"},"wordCount":344,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/","name":"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=","datePublished":"2020-12-07T21:08:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5ODExMCMzODYwMjMxIzIxOTQ4NTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=394714"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/394714\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=394714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=394714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=394714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}